3,4,5,4'-trans-tetramethoxystilbene (DMU-212) modulates the activation of NF-κB, AP-1, and STAT3 transcription factors in rat liver carcinogenesis induced by initiation-promotion regimen.
about
Herbal Medicine Offered as an Initiative Therapeutic Option for the Management of Hepatocellular Carcinoma.Cancer Chemoprevention by Phytochemicals: Nature's Healing Touch.Anti-tumor properties of cis-resveratrol methylated analogs in metastatic mouse melanoma cells.Effect of resveratrol analogue, DMU-212, on antioxidant status and apoptosis-related genes in rat model of hepatocarcinogenesis.Fangchinoline inhibits migration and causes apoptosis of human breast cancer MDA-MB-231 cells.Therapeutic Versatility of Resveratrol Derivatives.
P2860
3,4,5,4'-trans-tetramethoxystilbene (DMU-212) modulates the activation of NF-κB, AP-1, and STAT3 transcription factors in rat liver carcinogenesis induced by initiation-promotion regimen.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
3,4,5,4'-trans-tetramethoxysti ...... initiation-promotion regimen.
@en
3,4,5,4'-trans-tetramethoxysti ...... initiation-promotion regimen.
@nl
type
label
3,4,5,4'-trans-tetramethoxysti ...... initiation-promotion regimen.
@en
3,4,5,4'-trans-tetramethoxysti ...... initiation-promotion regimen.
@nl
prefLabel
3,4,5,4'-trans-tetramethoxysti ...... initiation-promotion regimen.
@en
3,4,5,4'-trans-tetramethoxysti ...... initiation-promotion regimen.
@nl
P2860
P50
P1476
3,4,5,4'-trans-tetramethoxysti ...... y initiation-promotion regimen
@en
P2093
Michał Cichocki
P2860
P2888
P356
10.1007/S11010-014-1983-9
P577
2014-02-13T00:00:00Z